Understanding the economics of Tuberculosis (TB) patients in the private sector

Start Date

Date published:

Project location

economics of Tuberculosis

Background

Despite free treatment offered by the government, the private sector plays a significant role in Tuberculosis (TB) treatment in India. The reasons for availing private facilities are dissatisfaction with public sector services, non-availability of public facilities in the neighbourhood, long waiting time etc. A literature review identified that only three studies (covered total of 102 patients) estimated the cost for the TB patients treated in the private sector. Two studies considered only multi-drug resistant TB patients, the third one collected out of pocket expenses data from a convenient sample of 32 drug susceptible TB patients. Therefore, there is a clear dearth of data on the economic burden of TB in the private sector in India.

Aim

The national strategic plan for TB (2017-2025) stated its intention to extend the umbrella of high-quality TB care and control to those treated in the private sector, highlighting private sector engagement (PPE) as an important strategy to eliminate TB. The primary objective of this study is to determine exposure to any PPE strategy components:

  1. Reduces out of pocket patient costs and incidence of catastrophic expenditure
  2. Reduces delay to correct diagnosis and appropriate treatment
  3. Improves medication adherence and treatment outcomes
  4. Improves patient satisfaction and retention

Research Methodology

In this prospective cohort study, approximately 1250 adult pulmonary TB patients seeking treatment from private providers will be sampled from five districts of five states. Patients will be sampled through notifications from private providers and chemists of the sampled districts. Each patient will be interviewed thrice: at intake, 3 months and 6 months of treatment using TB patient cost survey instrument developed by the World Health Organization and adapted for the Indian context.

Current Status

Applied for HMSC and ethics clearances

Field work will start after obtaining all necessary clearances

Lead

Health systems science

Dr Susmita Chatterjee

Program Head - Health Economics

Related Person

Palash Das

Research Fellow

External Investigators

Dr Nerges Mistry

Foundation for Medical Research, Mumbai

Dr Raghuram Rao

Central TB Division, MoHFW, Government of India, New Delhi

Partners

Central TB division, Ministry of Health and Family Welfare, Government of India

Foundation for Medical Research

Indian School of Business (ISB) Hyderabad

Funder

Bill & Melinda Gates Foundation

Share this Project

  • Icon facebook
  • Icon X
  • Icon Linkedin

Related Content

New study reveals alarming economic burden of Tuberculosis treatment in India

Date published: Node Type: Media release

Deconstructing the economic burden of tuberculosis in India

Date published: Node Type: Profile story

India has a long way to reach zero catastrophic costs goal for TB patients: Study

Date published: Node Type: Media release

Covid-19 restrictions may have exacerbated India's TB problems: study by The George Institute, India

Date published: Node Type: News

Economic Burden of Tuberculosis in India

Date published: Node Type: project